Alicia R. Boston Shoemake, General Counsel at Tetra Technologies (TTI), has demonstrated a clear selling bias in her recent insider transactions, with $528,493 in total sales outweighing $94,608 in purchases across 37 filings. Her activity has been concentrated exclusively in TTI, with no trades in other companies. The most recent transactions—two sales in early 2026—continued this trend, including a $106,868 disposition on March 14 and a $66,206 sale on February 28. Prior to these, her November 2025 sales totaled $104,433 and $48,529, supplemented by derivative transactions. In contrast, her buying activity has been sporadic and smaller in scale, with the last open-market purchases occurring in August 2025 for $20,770 and $16,424. The pattern suggests a gradual reduction in exposure, with no buys recorded in the past six months. While earlier filings show occasional acquisitions—such as a $13,132 purchase in February 2025—the overall direction leans toward divestment, particularly in the most recent quarter. The absence of any transactions flagged as option exercises or awards in 2026 further narrows the activity to outright sales.
AI-assisted summary